Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07618026 · ClinicalTrials.gov registry record · NA
Establishing Effects of Bacillus Clausii Probiotic Consumption on Gastrointestinal Health and Inflammation
A NA study, sponsored by Colorado State University.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT07618026 is a NA study that has completed, run by Colorado State University. The registered enrollment target is 55 participants.
The verdict
NCT07618026, a NA study, has completed, sponsored by Colorado State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
The study is a randomized, double-blind, crossover, placebo-controlled clinical intervention trial to test the effects of a commercial Bacillus (Shouchella) clausii probiotic compared to a placebo on gastrointestinal symptoms.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Bacillus (Shouchella) clausii CSI08
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2024-03-28 |
| Est. Completion | 2025-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07618026
The ClinicalTrials.gov registry entry for NCT07618026 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Colorado State University, which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07618026 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07618026 about?
NCT07618026 is a clinical study titled "Establishing Effects of Bacillus Clausii Probiotic Consumption on Gastrointestinal Health and Inflammation". The study is a randomized, double-blind, crossover, placebo-controlled clinical intervention trial to test the effects of a commercial Bacillus (Shouchella) clausii probiotic compared to a placebo on gastrointestinal symptoms.
What is the current status of trial NCT07618026?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2024-03-28. Estimated completion is 2025-03-31.
What interventions are being tested in trial NCT07618026?
The interventions under investigation include: Placebo (OTHER), Bacillus (Shouchella) clausii CSI08 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07618026?
This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.